About Clinica de Investigacion en Reumatologia y Obesidad
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Horizon Therapeutics Ireland DAC
2
Janssen Research & Development, LLC
2
Viela Bio (acquired by Horizon Therapeutics)
1
Clinical Trials at Clinica de Investigacion en Reumatologia y Obesidad
During the past decade, Clinica de Investigacion en Reumatologia y Obesidad conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study
2022-06-01
2024-06-29
Enrolling by invitation
156
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Clinica de Investigacion en Reumatologia y Obesidad
According to Clinical.Site data, the most researched conditions in "Clinica de Investigacion en Reumatologia y Obesidad" are
"Colitis, Ulcerative" (1 trials), "Crohn's Disease" (1 trials), "Diffuse Cutaneous Systemic Sclerosis" (1 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Sclerosis, Systemic" (1 trials). Many other conditions were trialed in "Clinica de Investigacion en Reumatologia y Obesidad" in a lesser frequency.
Clinical Trials Intervention Types at Clinica de Investigacion en Reumatologia y Obesidad
Most popular intervention types in "Clinica de Investigacion en Reumatologia y Obesidad" are "Drug" (4 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Golimumab" (2 trials), "Guselkumab" (2 trials), "JNJ-78934804" (2 trials) and "Daxdilimab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clinica de Investigacion en Reumatologia y Obesidad
The vast majority of trials in "Clinica de Investigacion en Reumatologia y Obesidad" are
5 trials for "All" genders.
Clinical Trials Status at Clinica de Investigacion en Reumatologia y Obesidad
Currently, there are NaN active trials in "Clinica de Investigacion en Reumatologia y Obesidad".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were undefined completed trials in Clinica de Investigacion en Reumatologia y Obesidad,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Clinica de Investigacion en Reumatologia y Obesidad, 0 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".